Bank of America
SLDB icon

Bank of America’s Solid Biosciences SLDB Stock Holding History

Bank of America’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,400
Closed -$160K – 7204
2019
Q4 		$160K Buy
2,400
+2,333
+3,482% +$257K ﹤0.01% 5756
2019
Q3 		$10K Buy
+67
New +$7.58K ﹤0.01% 6724

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America's SLDB Position: Q1 2026 in Review

Bank of America increased its Solid Biosciences (SLDB) stake by 12% in Q1 2026, buying an estimated $273K and bringing the position to 386,793 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #3883.

Bank of America first reported a position in SLDB in Q1 2018 and has held it in 33 quarters since. The position peaked at $4.87M in Q3 2025. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Bank of America held 386,793 shares of Solid Biosciences worth $2.78M as of Q1 2026.
  • Bank of America bought 42,499 Solid Biosciences shares in Q1 2026, an estimated $273K.
  • Solid Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3883 holding.
  • Bank of America first reported a position in Solid Biosciences in Q1 2018 and has held it in 33 quarters since.
  • Bank of America's Solid Biosciences position peaked at $4.87M in Q3 2025.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.